Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Loughlin

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
tert-Butyl 2-(3-acetyl-amino-2-oxo-1,2-dihydro-1-pyrid-yl)acetateN David Karis, Wendy A Loughlin, Ian D Jenkins, et al.
Bioorganic & Medicinal Chemistry|May 16, 2009
Glycogen phosphorylase inhibitory effects of 2-oxo-1,2-dihydropyridin-3-yl amide derivativesN David Karis, Wendy A Loughlin, Ian D Jenkins, et al.
Organic & Biomolecular Chemistry|July 16, 2004
Novel polymer-supported coupling/dehydrating reagents for use in organic synthesisKathryn E Fairfull-Smith née Elson, Ian D Jenkins, Wendy A Loughlin
Journal of Peptide Science : an Official Publication of the European Peptide Society|April 29, 2009
Synthesis of new modified truncated peptides and inhibition of glycogen phosphorylaseStephanie S Schweiker, Wendy A Loughlin, Christopher L Brown, et al.
European Journal of Medicinal Chemistry|January 12, 2017
Discovery of new nanomolar inhibitors of GPa: Extension of 2-oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitorsWendy A Loughlin, Ian D Jenkins, N David Karis, et al.
Psychopharmacology|March 30, 2016
Effects of prazosin and doxazosin on yohimbine-induced reinstatement of alcohol seeking in ratsD Funk, K Coen, S Tamadon, et al.
AIDS Care|June 19, 2004
Provider barriers to prescribing HAART to medically-eligible HIV-infected drug usersA Loughlin, L Metsch, L Gardner, et al.
Journal of Medical Genetics|March 1, 1991
Analysis of the origin of Turner's syndrome using polymorphic DNA probesS A Loughlin, A Redha, J McIver, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 7, 2013
The glycogen phosphorylase inhibitor 2-(3-benzylamino-2-oxo-1,2-dihydropyridin-1-yl)-N-(3,4-dichlorobenzyl)acetamideInessa Popova, Peter C Healy, Wendy A Loughlin, et al.
Human Genetics|March 1, 1994
Mutation screening by a combination of biotin-SSCP and direct sequencingA S Virdi, J A Loughlin, C M Irven, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
tert-Butyl 2-(3-acetyl-amino-2-oxo-1,2-dihydro-1-pyrid-yl)acetateN David Karis, Wendy A Loughlin, Ian D Jenkins, et al.
Bioorganic & Medicinal Chemistry|May 16, 2009
Glycogen phosphorylase inhibitory effects of 2-oxo-1,2-dihydropyridin-3-yl amide derivativesN David Karis, Wendy A Loughlin, Ian D Jenkins, et al.
Organic & Biomolecular Chemistry|July 16, 2004
Novel polymer-supported coupling/dehydrating reagents for use in organic synthesisKathryn E Fairfull-Smith née Elson, Ian D Jenkins, Wendy A Loughlin
Journal of Peptide Science : an Official Publication of the European Peptide Society|April 29, 2009
Synthesis of new modified truncated peptides and inhibition of glycogen phosphorylaseStephanie S Schweiker, Wendy A Loughlin, Christopher L Brown, et al.
European Journal of Medicinal Chemistry|January 12, 2017
Discovery of new nanomolar inhibitors of GPa: Extension of 2-oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitorsWendy A Loughlin, Ian D Jenkins, N David Karis, et al.
Psychopharmacology|March 30, 2016
Effects of prazosin and doxazosin on yohimbine-induced reinstatement of alcohol seeking in ratsD Funk, K Coen, S Tamadon, et al.
AIDS Care|June 19, 2004
Provider barriers to prescribing HAART to medically-eligible HIV-infected drug usersA Loughlin, L Metsch, L Gardner, et al.
Journal of Medical Genetics|March 1, 1991
Analysis of the origin of Turner's syndrome using polymorphic DNA probesS A Loughlin, A Redha, J McIver, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 7, 2013
The glycogen phosphorylase inhibitor 2-(3-benzylamino-2-oxo-1,2-dihydropyridin-1-yl)-N-(3,4-dichlorobenzyl)acetamideInessa Popova, Peter C Healy, Wendy A Loughlin, et al.
Human Genetics|March 1, 1994
Mutation screening by a combination of biotin-SSCP and direct sequencingA S Virdi, J A Loughlin, C M Irven, et al.
Pageof 5